3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Prostatic Neoplasms
5
Lung Neoplasms
5
Endometrial Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Meningioma
1
Interventions
Imatinib Mesylate
5
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Observation
×
90 days
×
Clear all
No trials found.